ELYPTA
Elypta is developing a metabolism-based liquid biopsy platform based on a new IVD laboratory assay kit and artificial intelligence algorithms trained by their clinical database. Elypta proudly sponsors the clinical trial series AURORAX to investigate applications in their lead indication renal cell carcinoma from surveillance of recurrence to monitoring treatment response. They also explore several other indications to understand the full potential for Elypta’s platform.
ELYPTA
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2017-05-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.elypta.com
Total Employee:
11+
Status:
Active
Contact:
+46 0 852 027 885
Email Addresses:
[email protected]
Total Funding:
32.62 M USD
Technology used in webpage:
Domain Not Resolving Pound Sterling 3 To 9 CcTLD Redirects OLM Amazon Stockholm Region
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Advisors List
Current Employees Featured
Founder
Investors List
Navigare Ventures
Navigare Ventures investment in Series A - Elypta
Hillclimber
Hillclimber investment in Series A - Elypta
Nina Capital
Nina Capital investment in Series A - Elypta
Chalmers Ventures AB
Chalmers Ventures AB investment in Series A - Elypta
Norrsken VC
Norrsken VC investment in Series A - Elypta
Industrifonden
Industrifonden investment in Series A - Elypta
Bonnier Ventures
Bonnier Ventures investment in Series A - Elypta
Sciety
Sciety investment in Seed Round - Elypta
Chalmers Ventures AB
Chalmers Ventures AB investment in Seed Round - Elypta
Norrsken VC
Norrsken VC investment in Seed Round - Elypta
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-10 | Elypta appoints Volker Liebenberg as CMO |
Official Site Inspections
http://www.elypta.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Elypta"
Elypta - Crunchbase Company Profile & Funding
Elypta proudly sponsors the clinical trial series AURORAX to investigate applications in their lead indication renal cell carcinoma from surveillance of recurrence to monitoring treatment …See details»
Elypta 2025 Company Profile: Valuation, Funding
Elypta General Information Description. Developer a metabolism-based liquid biopsy platform designed to prevent cancer mortality through earlier detection …See details»
Francesco Gatto, Founder and Scientific Advisor - Elypta
Francesco founded Elypta with his Ph.D. advisor Jens Nielsen in 2017 after spearheading the early entrepreneurial activities as interim CEO in 2015. Francesco obtained a B.Sc. and M.Sc. in Chemical Engineering from the …See details»
Elypta - Nordic Startups
Elypta Elypta’s liquid biopsy platform is based on the discovery that a panel of 19 metabolites - glycosaminoglycans (GAGs) - are specifically deregulated across several cancer types. ... Startup company name: Elypta AB Organization …See details»
Elypta AB Company Profile | Solna, Stockholm, Sweden
Find company research, competitor information, contact details & financial data for Elypta AB of Solna, Stockholm. Get the latest business insights from Dun & Bradstreet.See details»
Elypta - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Elypta . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board …See details»
Elypta - VentureRadar
Elypta’s liquid biopsy platform is based on the measurement and analysis of 20 metabolites; glycosaminoclycans; tracking a vital process in cancer. Machine learning is used to define and …See details»
Elypta - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Pre Seed Round - Elypta . 1: …See details»
Elypta – Advancing Cancer Detection
Elypta Receives ISO 13485:2016 Quality System Certification. Jul 5, 2023. The Roddenberry Foundation Awards Elypta $1 Million Grand Prize. Mar 28, 2023. Double multi-cancer …See details»
Elypta - Chalmers Ventures
Elypta is developing an exceptionally sensitive liquid biopsy platform for early detection and monitoring of cancer. Elypta’s assay kit enables the measurement of a novel panel of …See details»
Elypta - Bonnier Capital
Elypta focuses on cutting-edge technology that uses liquid biopsies to detect early-stage cancer. Since its foundation Elypta has been developing the world’s first blood- and urine-test …See details»
Elypta Company Profile - Office Locations, Competitors, Revenue …
Elypta has 5 employees at their 1 location and $11.35 m in total funding,. See insights on Elypta including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Elypta Company Information - Funding, Investors, and More
Elypta is a Stockholm-based biotechnology company focused on preventing cancer mortality through a liquid biopsy platform for detection and monitoring of the disease. Seedtable Score …See details»
The Science behind Elypta
Elypta AB, Scheeles väg 3, 171 65 Solna, Sweden +46 (0)8 520 27 885 [email protected]. Science MIRAM® Kit Clinical Studies News Team Careers Contact. ISO 13485:2016 ...See details»
Francesco Gatto - Innovators Under 35
Organization Elypta Region Europe ... In 2019 Elypta plans to begin two larger clinical trials in Europe and the US, each with 500 patients who have the most common type of kidney cancer. …See details»
Elypta AB - Stockholm, Sweden - bionity.com
Elypta is developing the first-ever metabolism-based liquid biopsy platform for early detection and closer follow-up of multiple cancer indications. The platform is inherently safe and convenient, …See details»
Elypta AB - EU-Startups
Elypta is a molecular diagnostic company focused on preventing cancer mortality by developing a liquid biopsy platform for detection and monitoring of the disease. The approach is based on …See details»
Apply - Elypta
Organization. Research institute affiliation required for sponsorship application. Information about samples to be analysed. Number of samples * Approx. count also acceptable (10s or 100s or …See details»
Elypta’s urine-based test shows recurrence of kidney cancer
1 day ago Elypta AB’s urine-based test correctly identified 90% of patients whose kidney cancer had returned, according to results from an ongoing study. The company’s metabolism-based …See details»
Elypta – Elypta raises $21 million Series A to develop metabolism …
Stockholm, June 20, 2022: Elypta, a Swedish diagnostics company aiming to commercialize the first metabolism-based liquid biopsy for early detection of any cancer, today announced the …See details»